Adicet Bio Inc [NASDAQ: ACET] traded at a low on Wednesday, posting a -2.24 loss after which it closed the day’ session at $0.96.
The results of the trading session contributed to over 461638 shares changing hands. Over the past one week, the price volatility of Adicet Bio Inc stands at 10.02% while the volatility over the past one month is 8.51%.
The market cap for ACET stock reached $79.11 million, with 82.40 million shares outstanding and 66.22 million shares in the current float. Compared to the average trading volume of 572.57K shares, ACET reached a trading volume of 461638 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adicet Bio Inc [ACET]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ACET shares is $6.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ACET stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Adicet Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 30, 2024. The new note on the price target was released on September 11, 2024, representing the official price target for Adicet Bio Inc stock.
The Average True Range (ATR) for Adicet Bio Inc is set at 0.09 The Price to Book ratio for the last quarter was 0.37, with the Price to Cash per share for the same quarter was set at 2.45.
How has ACET stock performed recently?
Adicet Bio Inc [ACET] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.21. With this latest performance, ACET shares dropped by -8.57% in over the last four-week period, additionally sinking by -24.41% over the last 6 months – not to mention a drop of -60.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACET stock in for the last two-week period is set at 46.66, with the RSI for the last a single of trading hit 47.86, and the three-weeks RSI is set at 45.27 for Adicet Bio Inc [ACET]. The present Moving Average for the last 50 days of trading for this stock 1.0642, while it was recorded at 0.9997 for the last single week of trading, and 1.4232 for the last 200 days.
Adicet Bio Inc [ACET]: Deeper insight into the fundamentals
Adicet Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.64 and a Current Ratio set at 10.64.
Insider trade positions for Adicet Bio Inc [ACET]
There are presently around $76.44%, or 77.67%% of ACET stock, in the hands of institutional investors. The top three institutional holders of ACET stocks are: ORBIMED ADVISORS LLC with ownership of 11.45 million shares, which is approximately 14.4769%. TANG CAPITAL MANAGEMENT LLC, holding 8.22 million shares of the stock with an approximate value of $$9.94 million in ACET stocks shares; and TANG CAPITAL MANAGEMENT LLC, currently with $$9.12 million in ACET stock with ownership which is approximately 9.5369%.
